Public Law 102-515 and its amendments identify reportable conditions for the National Program of Cancer Registries, therefore Nevada is following the International Classification of Diseases for Oncology classification system to determine reportability.
- All diseases with a behavior code of "/2," in situ disease, or "/3" malignant disease
- All solid tumors of brain and central nervous system, including meninges and intracranial endocrine structures with behavior codes of:
- "/0" benign disease
- "/1" disease of uncertain malignant potential
- "/2" in situ disease
- "/3" malignant disease
This includes:
- Diagnoses that include the following terminology are malignant neoplasms and are reportable:
- cancer carcinoma
- carcinoma in situ malignant
- leukemia lymphoma
- melanoma sarcoma
- Malignant diagnoses that are not histologically confirmed, but are described by one of the following ambiguous terms, are considered confirmed cases and are reportable:
- apparent, apparently most likely
- appears presumed
- comparable with probable, probably
- compatible with suspect, suspected
- consistent with suspicious (for)
- favors typical of
- malignant appearing
- Basal or squamous cell carcinoma originating in mucoepidermoid or genital sites. This includes VIN III, VAIN III, and AIN III
- A clinical diagnosis or any case that is stated to be cancer by a recognized medical practitioner, even if there is no histologic or cytologic confirmation
- Any reportable cancer listed on the death certificate
- Patients undergoing prophylactic or adjuvant therapy for a reportable condition
- Hematopoietic and lymphoid neoplasms